ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!BDX Company Profile and Key Details
Becton, Dickinson and Company
BDX Stock Price Chart
Stock Price Today
Becton, Dickinson and Company (BDX) stock declined over -0.22%, trading at $227.43 on NYSE, down from the previous close of $227.93. The stock opened at $226.47, fluctuating between $226.43 and $229.59 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Company Information
| Employees | 70000 |
| Beta | 0.43 |
| Sales or Revenue | $20.18B |
| 5Y Sales Change% | 0.094% |
| Fiscal Year Ends | September |
| Sector | Healthcare |
| Industry | Medical - Instruments & Supplies |
Frequently Asked Questions
Becton, Dickinson and Company (NYSE: BDX) stock price is $227.43 in the last trading session. During the trading session, BDX stock reached the peak price of $229.59 while $226.43 was the lowest point it dropped to. The percentage change in BDX stock occurred in the recent session was -0.22% while the dollar amount for the price change in BDX stock was -$0.50.
The NYSE listed BDX is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector. Becton, Dickinson and Company designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Elizabeth McCombs
Executive Vice President & Chief Technology Officer
Ms. Denise Fleming
Executive Vice President of Technology & Global Services and Chief Information Officer
Mr. Christopher J. DelOrefice
Executive Vice President & Chief Financial Officer
Ms. Shana Carol Neal
Executive Vice President & Chief People Officer
Ms. Francesca M. DeMartino
Senior Vice President & Head of Investor Relations
Michelle Quinn
Senior Vice President and Chief Ethics & Compliance Officer
Mr. Christopher DelOrefice
Executive Vice President & Chief Financial Officer
Mr. Thomas E. Polen Jr.
Pres, Chief Executive Officer & Chairman
Troy Kirkpatrick
Vice President of PR
Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D.
Senior Vice President, Chief Scientific Officer & Co-Chair of Scientific Advisory Board
Mr. David B. Hickey
Executive Vice President & Pres of Life Sciences Segment
Ms. Michelle Quinn
Executive Vice President & Gen. Counsel
Mr. Thomas J. Spoerel
Senior Vice President, Controller & Chief Accounting Officer
BDX's closing price is 3.97% higher than its 52-week low of $218.75 where as its distance from 52-week high of $251.99 is -9.75%.
Number of BDX employees currently stands at 70,000.
Official Website of BDX is: https://www.bd.com
BDX could be contacted at phone 201 847 6800 and can also be accessed through its website. BDX operates from 1 Becton Drive, Franklin Lakes, NJ 07417-1880, United States.
BDX stock volume for the day was 1.92M shares. The average number of BDX shares traded daily for last 3 months was 2.12M.
The market value of BDX currently stands at $65.30B with its latest stock price at $227.43 and 287.14M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com